121 related articles for article (PubMed ID: 7145465)
21. A novel adjuvant for use with a blood-stage malaria vaccine.
de Souza JB; Playfair JH
Vaccine; 1995 Oct; 13(14):1316-9. PubMed ID: 8585286
[TBL] [Abstract][Full Text] [Related]
22. Protection of mice against malaria by a killed vaccine: differences in effectiveness against P. yoelii and P. berghei.
Playfair JH; De Souza JB; Cottrell BJ
Immunology; 1977 Oct; 33(4):507-15. PubMed ID: 336522
[TBL] [Abstract][Full Text] [Related]
23. Saponin and other haemolysins (vitamin A, aliphatic amines, polyene antibiotics) as adjuvants for SRBC in the mouse. Evidence for a role for cholesterol-binding in saponin adjuvanticity.
Bomford R
Int Arch Allergy Appl Immunol; 1980; 63(2):170-7. PubMed ID: 7419284
[TBL] [Abstract][Full Text] [Related]
24. Evaluation of the immunoprophylactic potential of a killed vaccine candidate in combination with different adjuvants against murine visceral leishmaniasis.
Thakur A; Kaur H; Kaur S
Parasitol Int; 2015 Feb; 64(1):70-8. PubMed ID: 25316605
[TBL] [Abstract][Full Text] [Related]
25. Listeria monocytogenes inoculation protects mice against blood-stage Plasmodium yoelii infection.
Qi Z; Han X; Zhang Y; Wang J; Cao YM
Tohoku J Exp Med; 2013 Feb; 229(2):87-96. PubMed ID: 23303295
[TBL] [Abstract][Full Text] [Related]
26. Protective immunity to malaria: studies with cloned lines of rodent malaria in CBA/Ca mice. IV. The specificity of mechanisms resulting in crisis and resolution of the primary acute phase parasitaemia of Plasmodium chabaudi chabaudi and P. yoelii yoelii.
Jarra W; Brown KN
Parasite Immunol; 1989 Jan; 11(1):1-13. PubMed ID: 2648258
[TBL] [Abstract][Full Text] [Related]
27. Induction of long-lasting immunity to Plasmodium yoelii malaria with whole blood-stage antigens and copolymer adjuvants.
Hunter RL; Kidd MR; Olsen MR; Patterson PS; Lal AA
J Immunol; 1995 Feb; 154(4):1762-9. PubMed ID: 7836760
[TBL] [Abstract][Full Text] [Related]
28. Plasmodium berghei: immunologic enhancement of antigen by adjuvant addition.
Desowitz RS
Exp Parasitol; 1975 Aug; 38(1):6-13. PubMed ID: 1097263
[No Abstract] [Full Text] [Related]
29. Preliminary observations on the efficacy of a recombinant multistage Plasmodium falciparum vaccine in Aotus nancymai monkeys.
Collins WE; Galland GG; Barnwell JW; Udhayakumar V; Sullivan JS; Nace D; Tongren JE; Williams T; Roberts J; Shi YP; Lal AA
Am J Trop Med Hyg; 2005 Oct; 73(4):686-93. PubMed ID: 16222010
[TBL] [Abstract][Full Text] [Related]
30. Comparison of Corynebacterium parvum with Freund's complete adjuvant as a potentiator of the immune response to beta-human chorionic gonadotropin linked to tetanus toxoid.
Covey DC; Laurence KA
Am J Reprod Immunol (1980); 1984; 5(3):114-6. PubMed ID: 6588767
[TBL] [Abstract][Full Text] [Related]
31. Copolymer adjuvants in malaria vaccine development.
Hunter RL; Lal AA
Am J Trop Med Hyg; 1994; 50(4 Suppl):52-8. PubMed ID: 8172332
[TBL] [Abstract][Full Text] [Related]
32. Plasmodium yoelii and Plasmodium vinckei: the effects of nonspecific immunostimulation on murine malaria.
Cottrell BJ; Playfair JH; de Sousa B
Exp Parasitol; 1977 Oct; 43(1):45-53. PubMed ID: 330190
[No Abstract] [Full Text] [Related]
33. Saponin-based adjuvants create a highly effective anti-tumor vaccine when combined with in situ tumor destruction.
den Brok MH; Nierkens S; Wagenaars JA; Ruers TJ; Schrier CC; Rijke EO; Adema GJ
Vaccine; 2012 Jan; 30(4):737-44. PubMed ID: 22138178
[TBL] [Abstract][Full Text] [Related]
34. Adjuvanticity of dimethyl dioctadecyl ammonium bromide, complete Freund's adjuvant and Corynebacterium parvum with respect to host immune response to coccidial antigens.
Lillehoj HS; Lindblad EB; Nichols M
Avian Dis; 1993; 37(3):731-40. PubMed ID: 8257364
[TBL] [Abstract][Full Text] [Related]
35. Toxicity and dose determination of quillaja saponin, aluminum hydroxide and squalene in olive flounder (Paralichthys olivaceus).
Vinay TN; Park CS; Kim HY; Jung SJ
Vet Immunol Immunopathol; 2014 Mar; 158(1-2):73-85. PubMed ID: 23570990
[TBL] [Abstract][Full Text] [Related]
36. Immunization of cattle with a variant-specific surface antigen of Trypanosoma brucei: influence of different adjuvants.
Wells PW; Emery DL; Hinson CA; Morrison WI; Murray M
Infect Immun; 1982 Apr; 36(1):1-10. PubMed ID: 6281183
[TBL] [Abstract][Full Text] [Related]
37. Use of adjuvants in modulating the behaviour of Plasmodium berghei.
Khullar N; Sehgal S
Indian J Exp Biol; 1990 Dec; 28(12):1112-7. PubMed ID: 2099325
[TBL] [Abstract][Full Text] [Related]
38. Immunogenicity of a recombinant protein containing the Plasmodium vivax vaccine candidate MSP1(19) and two human CD4+ T-cell epitopes administered to non-human primates (Callithrix jacchus jacchus).
Rosa DS; Iwai LK; Tzelepis F; Bargieri DY; Medeiros MA; Soares IS; Sidney J; Sette A; Kalil J; Mello LE; Cunha-Neto E; Rodrigues MM
Microbes Infect; 2006 Jul; 8(8):2130-7. PubMed ID: 16797207
[TBL] [Abstract][Full Text] [Related]
39. Role of macrophages in experimental malaria: VI--Effect of Freund's complete adjuvant in Plasmodium berghei infected mice.
Pillai CR; Usha Devi C
J Commun Dis; 1999 Jun; 31(2):121-6. PubMed ID: 10810600
[TBL] [Abstract][Full Text] [Related]
40. Saponin adjuvant primes for a dominant interleukin-10 production to ovalbumin and to Trypanosoma cruzi antigen.
Tadokoro CE; Macedo MS; Abrahamsohn IA
Immunology; 1996 Nov; 89(3):368-74. PubMed ID: 8958049
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
